THE PHARMACOKINETIC REQUIREMENTS FOR THE PREDICTION OF DIGOXIN SERUM LEVELS FOLLOWING CHRONIC DOSING

被引:2
作者
BALANT, L
BAUER, F
HUNT, CA
ESCHEICHER, J
HUMAIR, L
机构
[1] UNIV GENEVA HOSP, GENEVA, SWITZERLAND
[2] HOP CHAUX FONDS, CHAUX FONDS, SWITZERLAND
[3] UNIV CALIF SAN FRANCISCO, SCH PHARM, SAN FRANCISCO, CA 94143 USA
来源
JOURNAL OF CLINICAL AND HOSPITAL PHARMACY | 1980年 / 5卷 / 01期
关键词
D O I
10.1111/j.1365-2710.1980.tb00947.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:35 / 42
页数:8
相关论文
共 10 条
[1]  
BALANT L, 1977, PHARM ACTA HELV, V52, P89
[2]   DO WE NEED A 3-COMPARTMENT MODEL FOR THE PREDICTION OF DIGOXIN BLOOD-LEVELS ON MULTIPLE DOSING [J].
BALANT, L ;
HUNT, CA .
JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1980, 5 (01) :31-34
[3]  
BAUER F, 1978, SCHWEIZ MED WSCHR, V108, P1891
[4]   COMPARTMENTAL ANALYSIS .1. LINDE, A PROGRAM USING AN ANALYTICAL METHOD OF INTEGRATION WITH CONSTITUENT MATRICES [J].
ESTREICHER, J ;
REVILLARD, C ;
SCHERRER, JR .
COMPUTERS IN BIOLOGY AND MEDICINE, 1979, 9 (01) :49-65
[5]   PHARMACOKINETICS OF BETA-METHYLDIGOXIN IN HEALTHY HUMANS .3. PHARMACODYNAMIC CORRELATIONS [J].
HINDERLING, PH ;
GARRETT, ER .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (03) :326-329
[6]  
JAMES F, 1971, MINUIT PACKAGE PROGR
[7]   PHARMACOKINETICS OF DIGOXIN - RELATIONSHIP BETWEEN RESPONSE INTENSITY AND PREDICTED COMPARTMENTAL DRUG LEVELS IN MAN [J].
KRAMER, WG ;
KOLIBASH, AJ ;
LEWIS, RP ;
BATHALA, MS ;
VISCONTI, JA ;
REUNING, RH .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (01) :47-61
[8]   PHARMACOKINETICS OF DIGOXIN - COMPARISON OF A 2-COMPARTMENT AND A 3-COMPARTMENT MODEL IN MAN [J].
KRAMER, WG ;
LEWIS, RP ;
COBB, TC ;
FORESTER, WF ;
VISCONTI, JA ;
WANKE, LA ;
BOXENBAUM, HG ;
REUNING, RH .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (04) :299-312
[9]  
LISALO E, 1977, CLIN PHARMACOKINET, V2, P1
[10]   ROLE OF PHARMACOKINETICS IN DRUG DOSAGE ADJUSTMENT .1. PHARMACOLOGIC EFFECT KINETICS AND APPARENT VOLUME OF DISTRIBUTION OF DIGOXIN [J].
REUNING, RH ;
SAMS, RA ;
NOTARI, RE .
JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 13 (04) :127-141